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Background: A solitary metastatic liver tumor of prostate cancer is extremely rare because liver metastasis occurs
as a part of systemic dissemination of prostate cancer. We herein report a successfully resected case of a solitary
metastatic liver tumor from prostate cancer almost 15 years after radical prostatectomy.
Case presentation: A 70-year-old male who had undergone radical prostatectomy for prostate cancer 15 years
previously presented to our hospital for treatment of a liver tumor. Serum prostate-specific antigen was elevated at 13.
77 ng/ml. Abdominal computed tomography revealed a solitary tumor with a diameter of 54 mm in segment 4 of the
liver. No metastatic lesions were found in other organs. The patient was given a diagnosis of a metastatic liver tumor from
prostate cancer, and he underwent medial segmentectomy. Microscopically, the resected specimen was composed of
eosinophilic tumor cells with oval nuclei and prominent nucleoli, which exhibited a cribriform pattern and a fused glands
pattern with positive prostate-specific antigen and prostatic acid phosphatase staining; these findings were compatible
with metastatic prostate cancer. Other than portal thrombosis that required anticoagulation, the patient made a
satisfactory recovery and was discharged on postoperative day 15.
Conclusion: To the best of our knowledge, this is the first report describing successful resection of a solitary metastatic
liver tumor from prostate cancer in the medical literature. In such a rare circumstance, hepatic resection for liver
metastasis of prostate cancer seems justified.
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A solitary metastatic liver tumor of prostate cancer is
extremely rare, as liver metastasis from prostate cancer
occurs through the portal system from lymph node
metastasis or carcinomatosis [1]. We herein report a
successfully resected case of a solitary metastatic liver
tumor from prostate cancer almost 15 years after
radical prostatectomy.Case presentation
A 70-year-old male who had undergone radical prosta-
tectomy for prostate cancer 15 years and 1 month previ-
ously presented for treatment of a liver tumor. The
patient had received adjuvant hormonal therapy for* Correspondence: h-kawai@jikei.ac.jp
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the Creative Commons license, and indicate ifprostate cancer using goserelin acetate and bicalutamide.
Eleven years after resection, local recurrence occurred,
and the patient underwent 70 Gy of external radiation
therapy; hormonal therapy was also switched at that
time from bicalutamide to flutamide while goserelin
acetate was continued. The local recurrence of prostate
cancer was successfully treated and had a complete
response. The patient had a past medical history of mul-
tiple arterial thromboses, including popliteal, femoral,
and mesenteric artery thrombosis; he was maintained on
3.5 mg of warfarin per day. Laboratory evaluation
revealed that serum prostate-specific antigen (PSA) was
elevated at 13.77 ng/ml. Enhanced computed tomog-
raphy (CT) revealed the presence of a solitary, low-
density, and hypovascular tumor with a diameter of
54 mm in segment 4 of the liver (Fig. 1). Magnetic
resonance imaging demonstrated a liver tumor with a
high intensity on T1-weighted images (Fig. 2a) and a lowis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Fig. 1 Enhanced computed tomography revealed a solitary, low-density,
and hypovascular tumor with a diameter of 54 mm in segment 4 of the
liver (arrow)
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weighted images (Fig. 2b) in the same area. No meta-
static lesions were found in other organs on positron
emission tomography-CT. With the diagnosis of a
solitary metastatic liver tumor from prostate cancer, the
patient underwent medial segmentectomy of the liver.
Macroscopic findings of the resected specimen revealed
a solid whitish tumor with maximum diameter of
55 mm with central hemorrhagic and necrotic changes
(Fig. 3). Microscopically, the resected liver tumor was
compatible with metastatic prostate cancer (Fig. 4). The
patient developed portal vein thrombosis on postopera-
tive day 6, which was successfully treated with anticoa-
gulation. Otherwise, the patient made a satisfactory
recovery and was discharged on postoperative day 15.
Serum PSA decreased to 0.54 ng/ml after hepatic resec-
tion. Nine months after hepatic resection, serum PSAa b
Fig. 2 Magnetic resonance imaging revealed a high-intensity tumor on T1-w
high intensity on T2-weighted images (b; arrowhead)increased to 6.99 mg/ml, and enhanced CT at 1 year
post-hepatic resection revealed a recurrent tumor in
segment 5 of the liver (Fig. 5). The patient has received
docetaxel chemotherapy for recurrent liver metastasis of
prostate cancer.
Conclusions
In 2013, prostate cancer was the most frequently diag-
nosed cancer in males (1.4 million) worldwide, while the
incidence is still low in developing countries [2]. In
2008, approximately 14% of prostate cancer worldwide
was diagnosed within the Asia-Pacific region, with three
out of every four being diagnosed in Japan (32%), China
(28%), or Australia (15%) [3]. The bone (90%), lung
(46%), and liver (25%) are well-known and common
metastatic sites of prostate cancer [1]. In general, liver
metastasis occurs as a part of systemic dissemination of
prostate cancer [4]. Therefore, solitary liver metastasis of
prostate cancer is extremely rare. Batson et al. referred
to the importance of the vertebral venous system
(Batson’s plexus) as a metastatic pathway of prostate
cancer. The vertebral venous system with their rich,
valveless ramifications and connections by-passes the
portal system, so this system offers a possible reason
why a solitary metastatic prostate cancer occurred. To
the best of our knowledge, this is the first report describ-
ing successful resection of a solitary metastatic liver
tumor from prostate cancer in the medical literature.
Although the utility of hepatic resection for patients
with liver metastases from colorectal cancer or endo-
crine tumors has been established, for patients with
non-colorectal, non-endocrine liver metastases, it
remains unclear because of the limited numbers of
patients in each primary tumor groups [5]. Adam et al.
reported 5-year overall survival rates of patients with
liver metastases from urologic cancer after hepatic resec-
tion of 66% in adrenal, 55% in testicular, and 38% in
renal cancer, respectively; furthermore, these authorseighted images (a; arrow) and a low-intensity tumor with surrounding
Fig. 3 Macroscopic findings revealed a solid whitish hepatic tumor with central hemorrhage and necrotic changes, and the maximum diameter
of the tumor was 55 mm (arrow)
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resection [5]. Herein, we also discuss portal vein throm-
bosis (PVT) after hepatectomy which is relatively rare
complication. Kuboki et al. reported that the incidence
rate of PVT after hepatectomy was 2.1% and that right-




Fig. 4 Microscopically, the resected specimen was composed of eosinophilic
cribriform and fused glands pattern by hematoxylin-eosin staining (a) and sta
phosphatase (c) (×100)postoperative bile leakage were independent risk factors
for PVT after hepatectomy [6]. Although this patient
had no risk factors for PVT after hepatectomy, he had a
past medical history of unidentified arterial thromboses,
so this might have caused PVT. Hepatic resection for a
solitary metastatic liver tumor from prostate cancer is100
b
tumor cells with oval nuclei and prominent nucleoli, which exhibited a
ined positive for prostate-specific antigen (b) as well as prostatic acid
Fig. 5 One year after hepatic resection, enhanced computed
tomography revealed a solitary, low-density, and hypovascular tumor
with a diameter of 10 mm in segment 5 of the liver (arrow)
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systemic metastatic work-up is negative. In such a rare
circumstance, hepatic resection for liver metastasis of
prostate cancer seems justified.
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